The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGusbourne Regulatory News (GUS)

Share Price Information for Gusbourne (GUS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 59.50
Bid: 58.00
Ask: 61.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.172%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 59.50
GUS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Setting of Offer Price

9 Oct 2006 07:00

Experian Group Limited09 October 2006 7 October 2006 Not for distribution, directly or indirectly, in or into the United States, Canada, Australia and Japan This announcement is not a prospectus but an advertisement. Investors should not subscribe for any transferable securities referred to in this announcement except on the basis of information in the prospectus, a copy of which is available from Experian Group Limited's registered office. Experian Group Limited Result of the Global Offer of £800 million of Experian shares - Offer Price set at 560 pence per ordinary share Experian Group Limited (Experian), the global information solutions company, ispleased to announce that its Global Offer has been completed successfully at aprice of 560 pence per share (the Offer Price). Don Robert, Chief Executive Officer of Experian, said: "We are delighted with the offer price for Experian's shares, valuing thecompany at £5.7 billion. The success of the offer reflects Experian's globalleadership position and its excellent growth potential. We look forward withconfidence to the future as an independent company." Details of Global Offer The Global Offer comprised a pre-emptive offer of new shares to existing GUS plcshareholders (excluding certain overseas shareholders) on a pro rata basis (theExisting Shareholder Offer) and a non pre-emptive offer to institutional andcertain other investors (the New Investor Offer). GUS shareholders applied for a total of £275 million under the ExistingShareholder Offer. Under the terms of the Global Offer, entitlements not takenup under the Existing Shareholder Offer were added to the New Investor Offer. Asa consequence, the New Investor Offer was £525 million and the Global Offerraised a total of £800 million before the payment of commissions, fees andexpenses of approximately £20 million. A shareholder holding 1,000 GUS shares,who applied for their full existing shareholder offer entitlement, would receive123 shares at the offer price. The shares being issued in the Global Offer represent approximately 14% ofExperian's issued ordinary share capital following the Global Offer. The total number of new Experian shares to be issued under the Global Offer isapproximately 143 million. Following the demerger from GUS and the Global Offer,Experian will have a total of approximately 1,020 million ordinary shares inissue, of which 15 million will be held in an ESOP trust. Application has been made for, and the Global Offer is conditional upon, interalia, admission of the Global Offer shares to listing on the Official List ofthe Financial Services Authority and to trading on the London Stock Exchange'smarket for listed securities (together Admission) becoming effective by 8.00a.m. on 11 October 2006 (or such later time or date as the Global Co-ordinatorsand Experian may agree). Subject to these conditions being satisfied, the GlobalOffer shares will be issued credited as fully paid and will rank pari passu inall respects with Experian's other ordinary shares. Conditional dealings in the Ordinary Shares are expected to commence at 8.00a.m. on 9 October 2006. It is expected that Admission will become effective and dealings in the GlobalOffer shares, together with shares received by shareholders from the demerger(together the Ordinary Shares), will commence no later than 8.00 a.m. on 11October 2006. Enquiries Experian Don Robert Chief Executive Officer 020 7495 0070Paul Brooks Chief Financial OfficerFay Dodds Director of Investor Relations Finsbury Rollo Head 020 7251 3801James Wyatt-Tilby This press release has been prepared by and is the sole responsibility ofExperian. Defined terms in this announcement have, unless the context otherwise requires,the same meaning given to them in the Prospectus. Merrill Lynch International and UBS Investment Bank are acting as joint globalco-ordinators, joint bookrunners and joint sponsors to Experian and for no oneelse in connection with the Global Offer and Admission and will not beresponsible to anyone other than Experian for providing the protections affordedto respective clients of Merrill Lynch International or UBS Investment Bank norfor providing advice in relation to the Global Offer or Admission, or thecontents of this announcement. JPMorgan Cazenove is acting as the Joint Lead Manager for Experian and for noone else in connection with the Global Offer and Admission and will not beresponsible to anyone other than GUS and Experian for providing the protectionsafforded to customers of JPMorgan Cazenove nor for providing advice in relationto the Global Offer or Admission, or the contents of this announcement. In connection with the Global Offer, Merrill Lynch International as stabilisingmanager, or any of its agents, may (but will be under no obligation to), to theextent permitted by applicable law, effect transactions with a view tosupporting the market price of the Experian shares at a level higher than thatwhich might otherwise prevail in the open market. Merrill Lynch is not requiredto enter into such transactions and such transactions may be effected on anystock market, over the counter market or otherwise. Such stabilising measures,if commenced, may be discontinued at any time and may only be undertaken duringthe period from 7 October 2006 up to and including 6 November 2006. Except asrequired by law or regulation, neither the stabilising manager nor any of itsagents intends to disclose the extent of any stabilising transactions under theGlobal Offer. This announcement is not an offer to sell or the solicitation of an offer to buyor subscribe for securities in the United States, Canada, Japan or Australia orany other jurisdiction in which such offer or solicitation is unlawful andshould not be relied upon in connection with any decision to acquire the OfferShares or any other Experian securities. None of the securities mentioned herein are being registered, and there is nointention to register the securities under the US Securities Act of 1933 asamended. The securities mentioned herein may not be offered or sold in theUnited States absent registration or an exemption from registration under the USSecurities Act of 1933, as amended, and the rules and regulations thereunder. Nopublic offering of securities is being made in the United States. This document does not constitute an offer of securities to the public in theUnited Kingdom. This announcement is directed only at (i) persons who haveprofessional experience in matters relating to investments and who fall withinArticle 19(5) of the Financial Services and Markets Act 2000 (FinancialPromotion) Order 2005 (the "Order") or (ii) persons falling within Article 49(2)(a) to (d) (high net worth companies, unincorporated associations, etc.) of theOrder or to whom it may otherwise lawfully be communicated (all such personstogether being referred to as "relevant persons") or in circumstances in whichsection 21 of the FSMA does not apply to the Company. Any person who is not arelevant person must not act or rely on this communication or any of itscontents. In the United Kingdom, any investment or investment activity to whichthis communication relates is available only to relevant persons and will beengaged in only with relevant persons. Certain statements made are forward-looking statements. Such statements arebased on current expectations and are subject to a number of risks anduncertainties that could cause actual events or results to differ materiallyfrom any expected future events or results referred to in these forward-lookingstatements. Information in this announcement or any of the documents relating to the GlobalOffer can not be relied upon as a guide to future performance. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
31st Jan 20247:00 amRNSTrading Statement
19th Jan 20244:20 pmRNSRefinancing of existing loan facilities
17th Jan 20247:00 amRNSBoard Changes and CEO Designate Appointment
4th Jan 202412:26 pmRNSIssue of Equity
21st Dec 20237:00 amRNSAuditor Change
30th Nov 20237:00 amRNSDirectorate Change
14th Nov 20237:00 amRNSShort term Unsecured Loan & Extension of Warrants
3rd Nov 20233:00 pmRNSIssue of Equity
26th Oct 20237:00 amRNSWarrant Exercise/PDMR Dealings
19th Oct 20237:00 amRNSHarvest Report
28th Sep 20237:00 amRNSInterim results to 30 June 2023
6th Sep 20237:00 amRNSBoard Change and Appointment of Interim CEO
1st Sep 20237:00 amRNSIssue of Equity
29th Jun 20232:42 pmRNSResult of AGM
27th Jun 20237:00 amRNSBoard Change
7th Jun 20237:00 amRNSFinal Results
21st Mar 20237:00 amRNSDirectorate Change
14th Feb 202312:12 pmRNSAIM Rule 17 Notification
31st Jan 20237:00 amRNSTrading Update
16th Jan 20231:32 pmRNSIssue of Equity
20th Dec 20227:00 amRNSGrant of Share Options
16th Dec 202210:30 amRNSIssue of Equity
14th Dec 20227:00 amRNSExtension of the final exercise date of Warrants
27th Oct 20227:00 amRNSHarvest Report
4th Oct 20221:51 pmRNSIssue of Equity
29th Sep 20227:00 amRNSInterim results to 30 June 2022
6th Sep 20227:00 amRNSChange of Adviser
22nd Aug 20227:00 amRNSDirectorate Change
15th Aug 20227:00 amRNSTrading Update, Refinancing & Land Purchase
30th Jun 20222:00 pmRNSResult of AGM
6th Jun 20227:00 amRNSFinal Results
3rd May 202210:15 amRNSIssue of Equity
29th Mar 202212:10 pmRNSIssue of Equity
2nd Mar 20229:30 amRNSIssue of Equity
10th Feb 20227:00 amRNSTrading Update
17th Dec 20217:00 amRNSCompletion of Warrant Issue
15th Dec 20213:50 pmRNSFurther re Issue of Warrants
15th Dec 20217:00 amRNSResult of Open Offer and Issue of Warrants
22nd Nov 20217:00 amRNSLaunch of Open Offer and Posting of Circular
2nd Nov 20214:34 pmRNSDirector/PDMR Shareholding
1st Nov 20217:00 amRNSResult of Warrant Exercise and Debt Conversion
18th Oct 20214:30 pmRNSApplication for Admission
18th Oct 20212:10 pmRNSResult of ABB
18th Oct 20217:01 amRNSPlacing and Subscription
18th Oct 20217:00 amRNSFunding Update
30th Sep 20217:00 amRNSInterim Results to 30 June 2021
10th Aug 20217:38 amRNSIssue of Equity
23rd Jul 20217:00 amRNSDirector/PDMR Shareholding
22nd Jul 20217:00 amRNSTrading and Capital Structure Update
19th Jul 20211:00 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.